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EDITORIAL
From the ureteric bud to the penome
The kidney collecting system arises through branch-
ing morphogenesis of the ureteric bud (UB). Key signals
regulating the process are derived from the surrounding
metanephric mesenchyme and stroma. After many iter-
ations of branching, the tree that becomes the collecting
system is formed [1]. Aberrations are thought to alter
nephron number, possibly predisposing to hypertension
and progressive renal disease [2]. The branching process
may be exploitable for tissue engineering purposes [3]. As
data accumulates, the clinical ramifications of branching
are becoming broader and broader.
It is customary to divide collecting system develop-
ment into stages, but different investigators have parsed
them differently. This is not the place to argue why the
particular division that follows makes more sense than
others; suffice it to say that it seems reasonable to con-
ceive of a staged process consisting of ureteric bud out-
growth (stage 1), rapid branching (stage 2), a slowing
down of branching (stage 3), and the stopping of branch-
ing and tubular differentiation/maintenance (stage 4).
In this scheme, nearly all branching occurs in stage 2
and stage 3. Key questions for the field include: What is
the molecular basis of the switching mechanism between
each stage? And where do all the genes that mutational
and in vitro studies have implicated as important for col-
lecting system development—like the gene described in
this issue of Kidney International by Araki et al [4]—fit
into this scheme?
Although much work still needs to be done, a few gen-
eralizations can be attempted. In vitro studies strongly
suggest that growth factors (acting singly or in combina-
tion) can, in the appropriate extracellular matrix context,
function as switches that move the developing tree from
one stage to the next. And if one views the genetic cir-
cuitry of UB branching as a network of linked nodes (e.g.,
an airline route map), mutational data in both mouse and
humans suggest that certain genetic pathways constitute
hubs of varying importance [5]. For example, for stage
1 (UB outgrowth), the glia-derived neurotrophic factor
(GDNF)-ret axis (together with interacting genes) is the
equivalent of Chicago’s O’Hare Airport—with all major
airlines routed through this hub because disruption of
this pathway leads to renal agenesis. In stage 4 (differ-
entiation/maintenance), recent data on cystic disease are
consistent with the idea that the genes regulating ciliary
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morphogenesis and function are something of a minor
hub—“minor” because there seem to be other important
parallel pathways that are involved in stage 4 morpho-
genesis. So, in contrast with the genes directly linked to
the GDNF-ret axis in stage 1 (O’Hare), the ciliary genes
in stage 4 are more like Las Vegas Airport—a place that
many airlines travel to and one that is essential to the fi-
nancial existence of some, but most can stay in business
without going there.
What is the hub for phase 2 and phase 3? Or rather,
what is the O’Hare or Las Vegas Airport for the net-
work of genes that regulates branching? Perhaps there is
none. Knockout data does not yet support the existence
of such hubs, or at least major ones. In vitro data from
cell culture, organ culture, and isolated UB culture are
consistent with a variety of redundancy-type arguments,
again suggesting that there is no bottleneck hub. Is it pos-
sible that the network is so decentralized that any in vivo
disruption of individual nodes leads to rerouting around
the disruption that does not ultimately affect the outcome
in terms of the number of UB branching events (and thus
nephron number)? That may well be. For stages 2 and 3,
closing of the airport in Chicago during a blizzard does
not prevent one from traveling between Los Angeles and
New York City. And if Los Angeles Airport (LAX) is
closed, one can fly out of Orange County. If both JFK
and LaGuardia are closed, one can fly into Newark. And
so on. For the routing map in stages 2 and 3 is very
different from stage 1; there appear to be no “super-
hubs,” but instead, dozens of equivalent nodes. The rout-
ing through O’Hare, LAX, and JFK is not very different
from routing through the Minneapolis and Las Vegas air-
ports, which might not be all that different from Albu-
querque and Omaha and Fargo. This may be why studies
have not detected a hub of comparable importance the
GDNF-ret axis in stage 1, or even the ciliary genes of
stage 4.
These generalizations seem to hold for stage 2 and
stage 3 as long as one does not include genes such as
signaling molecules that pleiotropically regulate many
different basic cellular processes. About a decade ago,
a number of intracellular kinases, including protein ki-
nase C (PKC) and phosphoinusitide-3-kinase (PI3K),
were implicated in the branching of cultured renal ep-
ithelial cells in three-dimensional matrices [6, 7]. Subse-
quent work in organ culture also implicated these genes
in branching of the UB [8]. Because so many pathways
feed through them, these kinases, in a sense, could be
considered some sort of hub. But they are key to so
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many cellular processes necessary for UB growth and
branching—motility, apoptosis, cell shape changes, pro-
liferation, basement membrane interactions, and so on—
that it is hard to think of them as true morphogenetic
hubs that are relatively specific to stages 2 and 3 because
they seem to be involved in just about everything. How-
ever, it is plausible that the search for genes regulated by
these kinases may lead to the identification of important
nodes and even hubs that are specific to stage 2 and stage
3 branching. Following the targets of essential kinases still
makes a lot of sense.
This is what continues to make differential screen-
ing approaches like the one taken by Araki et al [4],
which aim to identify genes expressed under various
“plus-minus” conditions, interesting. Differential screen-
ing methods have been used to identify a number of genes
that seem to be involved in branching. The question is:
How involved is “involved?” That has been very hard
to sort out. As already discussed, one reason may be that
there are many equivalent nodes in the branching process
and no real hubs. Part of the problem is the difficulty in
reconciling in vitro developmental biology with genetic
approaches; part of the problem is also a battle of cultures
between investigators who favor one type of approach
over the other. Fortunately, with the growing realization
that knockout and transgenic mice can shed only limited
insight on many key problems in the field of nephrogen-
esis, the situation seems to be improving, if slowly.
Araki et al have found a new gene, metanephros de-
rived tubulogenic factor (MTF), that is regulated by PKC
during kidney development, and this gene appears to be
involved in UB branching [4]. At the moment, it is unclear
whether this is one of a large number of nodes involved
in Stage 2 or Stage 3 branching, or something greater,
but the approach of using differential screening to link
one pathway to another could conceivably lead to the
identification of some kind of branching hub, perhaps not
equivalent to the GDNF-ret axis (O’Hare) in Stage 1, but
then again, that awaits more detailed analysis of its role
in branching.
Branching is so fascinating because it is integral to so
many natural processes, living and nonliving. And one
must not forget the prevalence of tree metaphors in vi-
sual art, mythology, poetry, and prose. Part of the attrac-
tion of trying to understand branching lies not only in
the possibility of applying mathematics and physical sci-
ence approaches to a process of tremendous biologic and
clinical interest (i.e., systems biology); it is important to
bear in mind that much of the allure, even for scientists
(or perhaps especially for scientists), is metaphorical. In
a recently published novel, a neurotic depressed scien-
tist imagines “an infinite tree that he could climb and
climb, following its endlessly bifurcating branches until
he reached a fluffy cloud that would forever hide him
from the rest of the world. [9]” Although active experi-
mentalists do not generally talk about it publicly, either
because there is no forum or because they are hesitant
to come to terms with nonobjective factors involved in
the scientific enterprise, one cannot discount the impact
of such musings on the problem of scientific problem-
finding and problem-solving.
The paper in the current issue of Kidney International
adds yet another gene that must be considered as we de-
velop models of the genetic circuitry of UB branching.
The challenge is a big one. If a problem ever demanded a
systems approach—in the broadest sense—branching is
it. Work on the branching transcriptome is under way, as is
mathematical modeling and the application of engineer-
ing approaches to biologic branching, but much of the
preceding discussion is about something bigger that ex-
tends beyond the goal of systems biology—the so-called
systeome. Rather, it might be termed a penultimate-
ome—perhaps called the penome?—that seeks to ex-
plore the links between the sciences and humanities, not
in an airy metaphysical manner, but by using the criti-
cal academic eye to examine the data, broadly construed,
that exists in the sciences and arts, searching for inter-
faces, intersections, and possibly even general principles.
How far can we go before it all gets too murky for our
scientific taste? The long-sought unification of all fields,
dubbed “consilience” a few years ago [10], seems too
ambitious to this experimental nephrologist. But an in-
termediate step seems, at least at the moment, not only
plausible but desirable. Is there some middle ground be-
tween waxing transcendent and detailed quantitative de-
scriptions of reality—and if so, where is that ground? In
other words, if we concede that the extreme ends of the
arts and sciences may never meet, where in the spec-
trum is there a point that they do meet, and more im-
portantly, how do we define it? Will the product of such
an effort look more like a personal essay, a humanities
paper, a scientific report or some kind of hybrid that con-
stitutes a new form? Almost half a century after the fa-
mous two-culture debate began [11], where do we stand?
We need to find out by delving deeply, broadly, and open-
mindedly into very specific problems in order to explore,
using available approaches that are consistent with aca-
demic rigor, how far we can get. There is a lot to gain
by focusing an abstract debate on a concrete problem,
and the answers may prove surprising to many in both
the sciences and arts. Branching is a ripe area for such an
exploration.
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